ArticleJournal of equine rehabilitation2025
Substance withdrawal during psychotherapy incorporating equines: A preliminary investigation of the role of neurotransmitters during treatment.
Article in Journal of equine rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Substance withdrawal presents a barrier to substance use disorder (SUD) recovery in part due to symptoms implicating neurotransmitters and their metabolites. Despite this relationship, research investigating alternative treatments such as psychotherapy incorporating equines (PIE) have primarily targeted vital signs and cortisol concentrations. Previous research has also proposed benefits of human-horse physiological coupling, but the role of neurotransmitters in the relationship between humans and horses during PIE has not yet been investigated. The purpose of this study was to characterize neurotransmitter concentrations of humans and horses throughout PIE in withdrawing SUD patients and determine neurotransmitter involvement in human-horse physiological coupling. Saliva samples were collected from humans (n = 6) and horses (n = 4) immediately prior to and following PIE sessions in the first and second week of SUD treatment. Concentrations of 3-methoxytyramine (3-MT) in the second week of treatment increased (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.